If you enjoy this content, please share it with a colleague
RELATED CONTENT
The U.S. Food and Drug Administration (FDA) released updated requirements for a mammography facility to extend its Mammography Quality Standards Act (MQSA) certification for digital breast tomosynthesis (DBT) systems.
The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the next decade.
The U.S. Food and Drug Administration (FDA) released an updated Mammography Quality Standards Act and Program (MQSA) Scorecard, which offers answers to the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month.
The U.S. Food and Drug Administration (FDA) reports it has revoked the Mammography Quality Standards Act (MQSA) certificate for AP Diagnostic Imaging Inc., a facility at 1692 Oak Tree Road in Edison, New Jersey. The facility has ceased performing mammography.
The U.S. Food and Drug Administration (FDA) has put out a public safety notice asking expectant parents not to use ultrasound systems without a medical need.
Early detection is an important and valuable tool in the continuing fight against breast cancer. Research has found that cancers discovered during early screening exams are often smaller in size and still confined to the breast compared to those found later. When considering these two factors, the size and spread of breast cancer — the most important predictors of prognosis for women with the disease — early detection has become a focal point in cancer care. As a result, the American Cancer Society (ACS) has established guidelines that recommend women over 40 undergo annual screening mammograms.
September 10, 2014 — The U.S. Food and Drug Administration (FDA) reports it has revoked the Mammography Quality Standards Act (MQSA) certificate for Advanced Diagnostic Inc., a facility at 2300 W. Peterson Ave. in Chicago. The facility has ceased performing mammography.
Breast cancer is a disease usually associated with women, as reflected by pink ribbons and gear, but men get it too, albeit rarely.
Today, only 12 percent of breast cancers in the United States are treated with accelerated partial breast irradiation (APBI). Breast brachytherapy is a form of APBI that delivers radiation dose from within the breast and tumor cavity using a tiny radioactive pellet of iridium-192. The clinical benefits of this targeted approach to radiation delivery are clear — reduced radiation exposure to healthy tissue, better cosmetic results and fewer side effects, and allowing more future treatment options in the event of a recurrence or new primary cancer.
The majority of certified breast imaging facilities now have full-field digital mammography (FFDM) imaging systems. This is according to the U.S. Food and Drug Administration’s (FDA) data on the Mammography Quality Standards Act’s (MQSA) program and facilities.